Urinary tract infection (peds): Difference between revisions

(Text replacement - "<" to "<")
Line 59: Line 59:
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.16–0.41  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.16–0.41  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 1–3  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 1–3  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 1–3  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 1–3  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 1–3  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 1–3  
Line 78: Line 78:
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.31–0.83  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.31–0.83  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 2–6  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 2–6  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 3–7  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 3–7  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 2–5  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 2–5  
Line 115: Line 115:
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | –  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | –  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.04–4.91  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.04–4.91  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–27  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–27  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–30  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–30  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–25  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–25  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–33
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–33
|- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12"
|- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12"
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="2" class="font12" | Bacteria on Gram stain  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" rowspan="2" class="font12" | Bacteria on Gram stain  
Line 134: Line 134:
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | –  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | –  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.03–0.23  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.03–0.23  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–2  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1–2
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1–2
|- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12"
|- style="font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12"
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Combined tests  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | Combined tests  
Line 164: Line 164:
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | –  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | –  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.00–0.02  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | 0.00–0.02  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1  
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | &lt;1
| valign="top" bgcolor="#ffffff" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin: 0px 0px 9px;" class="font12" | <1
|}
|}
</div>  
</div>  
<br> <span style="color: rgb(51, 51, 51);" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient A: Female patient in ED, &lt;1 year old, fever with no definitive source on examination, pretest probability of UTI is 7%.</font></span>  
<br> <span style="color: rgb(51, 51, 51);" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient A: Female patient in ED, <1 year old, fever with no definitive source on examination, pretest probability of UTI is 7%.</font></span>  


<span style="color: rgb(51, 51, 51); font-family: Verdana,Arial,Helvetica,sans-serif;" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient B: Male patient in ED, &lt;1 year old, circumcised, fever with no definitive source on examination, pretest probability of UTI is 0.5%.</font></span>  
<span style="color: rgb(51, 51, 51); font-family: Verdana,Arial,Helvetica,sans-serif;" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient B: Male patient in ED, <1 year old, circumcised, fever with no definitive source on examination, pretest probability of UTI is 0.5%.</font></span>  


<span style="color: rgb(51, 51, 51); font-family: Verdana,Arial,Helvetica,sans-serif;" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient C: Male patient in ED, &lt;1 year old, uncircumcised, fever with no definitive source on examination, pretest probability of UTI is 8%.</font></span>  
<span style="color: rgb(51, 51, 51); font-family: Verdana,Arial,Helvetica,sans-serif;" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient C: Male patient in ED, <1 year old, uncircumcised, fever with no definitive source on examination, pretest probability of UTI is 8%.</font></span>  


<span style="color: rgb(51, 51, 51); font-family: Verdana,Arial,Helvetica,sans-serif;" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient D: Female patient in ED, 2–6 years old, no fever but GU symptoms, pretest probability of UTI is 6.5%.</font></span>  
<span style="color: rgb(51, 51, 51); font-family: Verdana,Arial,Helvetica,sans-serif;" class="Apple-style-span"><font style="font-size: 11px; line-height: 16px; margin: 0px 0px 9px;" class="font11">Patient D: Female patient in ED, 2–6 years old, no fever but GU symptoms, pretest probability of UTI is 6.5%.</font></span>  

Revision as of 16:41, 23 January 2017

This page is for pediatric patients; see Acute cystitis for adult patients.

Background

  • After 1yr of age, occult UTI with normal UA extremely rare
  • After 2yr of age, UTI remains common in girls (but associated with symptoms)
  • Associated with bacteremia in up to 30% of infants between 4-8wk of age
  • Do not use nitrofurantoin in children (need bloodstream penetration)
  • UTI in adolescent girl is suggestive of intercourse

Clinical Features

  • Infants/young children: Fever without other source
  • Older children: Urinary complaints, abd/back pain

Differential Diagnosis

Pediatric Abdominal Pain

0–3 Months Old

3 mo–3 y old

3 y old–adolescence

Pediatric fever

Evaluation

Labs

  • Urinalysis
    • Obtain clean catch specimen OR cath UA
      • Neg UA = neg LE, nit, GS & <5 WBC
    • Bag urine results in 83% false positive; only useful if negative
      • UTI diagnosis cannot be established reliably through bag urine culture (Evidence A; strong recommendation; AAP 2011)
  • Urine culture
    • Send on all patients except for:
      • 1. Low-risk patients with normal UA and another explanation for symptoms
      • 2. Older adolescent females with very high post-test probability without severe illness
    • 20% of +Urine culture will have negative UA

Test Characteristic Ranges Post-test Probability (%) of UTI in Different Patients
Test Sensitivity (%) Specificity (%) Test Result LR Patient A Patient B Patient C Patient D Patient E
Leukocyte esterase 67–85 81–92 + 3.5–10.6 21–45 2–5 23–49 20–43 26–52
0.16–0.41 1–3 <1 1–3 1–3 2–4
Nitrite* 21–69 95–99 + 4.2–69 24–84 2–26 26–86 22–83 29–87
0.31–0.83 2–6 <1 3–7 2–5 3–8
Leukocytes on microscopy 51–91 45–91 + 0.90–10.1 6–43 0–5 7–47 6–41 8–50
0.10–1.09 1–8 0–1 1–9 1–7 1–10
Bacteria on microscopy 46–96 11–96 + 0.5–24.0 4–64 0–11 4–68 3–63 5–70
0.04–4.91 <1–27 <1–2 <1–30 <1–25 <1–33
Bacteria on Gram stain 80–97 87–99 + 6.2–97 32–88 3–33 35–89 30–87 38–91
0.03–0.23 <1–2 <1 <1–2 <1–2 <1–2
Combined tests                  
Any positive test on dipstick 99–100 63–70 + 2.7–3.3 13–20 1–2 19–22 16–19 21–25
0.00–0.02 <1 <1 <1 <1 <1


Patient A: Female patient in ED, <1 year old, fever with no definitive source on examination, pretest probability of UTI is 7%.

Patient B: Male patient in ED, <1 year old, circumcised, fever with no definitive source on examination, pretest probability of UTI is 0.5%.

Patient C: Male patient in ED, <1 year old, uncircumcised, fever with no definitive source on examination, pretest probability of UTI is 8%.

Patient D: Female patient in ED, 2–6 years old, no fever but GU symptoms, pretest probability of UTI is 6.5%.

Patient E: Female patient in ED, adolescent age range, no fever but urinary symptoms, pretest probability of UTI is 9%


Management

<1mo

1mo - 2yo

  • Ceftriaxone 50mg/kg in ED
  • Cephalexin 50-100mg/kg/d in 4 divided doses x14d
    • Maximum dose (all ages) 4g/24hr

>2yo

  • Cephalexin 50-100mg/kg/d in 4 divided doses x7d
  • Amoxicillin
    • Mild to moderate infections (>40kg): 500mg PO BID for x10-14d

>13yr adolescent

  • Consider 3 day course of treatment

Disposition

Admit

  • <1 month old
  • Toxic
  • Inability to tolerate POs

Discharge

  • 1mo - 2yr, who are well-appearing and not vomiting
    • 24-hour follow up
  • >2 years old
    • 48-hour follow up

See Also

References